2021 United States Retina Atlas Featuring the Market Scope Exclusive MedOp Index(TM) Analysis
発行: Market Scope, LLC
The Retina Atlas offers strategic insights into the top potential markets in the US by providing demographic information of selected metropolitan populations; profiles of selected metropolitan areas and applicable retinal treatment opportunity; current estimates for retina surgery volume by metropolitan area; current estimates for retina surgeons by metropolitan area; and a comprehensive directory of US ophthalmic practices performing retinal IVTs and vitrectomies.
The allocation of the population with retinal disease is calculated by combining the prevalence rates by age group from Market Scope's comprehensive retinal disease model with the age distribution of each geography. We also consider the varying rates of adult diabetes throughout the US. The different procedure volumes and practice size are considered in the distribution of procedures. Retinal treatment opportunity is estimated with multi-factor criteria using Market Scope's MedOp Index™ Analysis. Factors in this analysis include the demographic makeup of a geography-including age distribution and health metrics-and the volume and concentration of retina surgeons.
The "2021 United States Retina Atlas"provides a geographic analysis of retinal treatment opportunity and key demographic metrics in 85 US metropolitan areas. The atlas identifies potential based on a variety of factors, which allows us to rank metros by opportunity and offers strategic insights into the top potential markets in the US.
Featured in the atlas is the Med/Op Index™ Analysis, a proprietary new index developed to estimate the market opportunity for each metropolitan area. This proprietary index identifies the potential based on patient demographics, procedure volumes, retina providers, and other factors.
The Retina Atlas can be used to evaluate market potential, identify growth opportunities, and allocate sales resources.